AI-generated summary
The authors randomized patients with head and neck cancer receiving radiochemotherapy to a laser photobiomodulation group (660 nm) or a simulated-procedure control group. The authors report that laser photobiomodulation was not effective in preventing oral mucositis, salivary hypofunction, or referred pain, though oral mucositis severity was reported as lower in the laser group.
- Who or what was studied
- Patients with head and neck cancer undergoing radiochemotherapy
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe whether the groups differed significantly in oral mucositis severity, and the group sizes were modest (30 and 24).
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 2 J/cm2
- Power
- 86.7 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Oral mucositis, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.